SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-048357
Filing Date
2017-09-15
Accepted
2017-09-15 21:44:03
Documents
1
Period of Report
2017-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 v475323_4.html 4  
1 FORM 4 v475323_4.xml 4 4034
  Complete submission text file 0001144204-17-048357.txt   5505
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address
Wu Yue Alexander (Reporting) CIK: 0001682419 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 171088876